142 related articles for article (PubMed ID: 23390491)
1. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.
Maurer M; Aberer W; Bouillet L; Caballero T; Fabien V; Kanny G; Kaplan A; Longhurst H; Zanichelli A;
PLoS One; 2013; 8(2):e53773. PubMed ID: 23390491
[TBL] [Abstract][Full Text] [Related]
2. Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study.
Campos RA; Valle SO; França AT; Cordeiro E; Serpa FS; Mello YF; Malheiros T; Toledo E; Mansour E; Fusaro G; Grumach AS
Sao Paulo Med J; 2014; 132(5):261-5. PubMed ID: 25054967
[TBL] [Abstract][Full Text] [Related]
3. Review of icatibant use in the Winnipeg Regional Health Authority.
Cai G; Barber C; Kalicinsky C
Allergy Asthma Clin Immunol; 2020 Nov; 16(1):96. PubMed ID: 33292436
[TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open-label study.
Hide M; Wang Y; Dote N; Miyakawa K; Sugiura K; Ishida K
J Dermatol; 2023 Nov; 50(11):1473-1477. PubMed ID: 37381768
[TBL] [Abstract][Full Text] [Related]
5. Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
Riedl MA; Farkas H; Aygören-Pürsün E; Psarros F; Soteres DF; Staevska M; Cancian M; Hagin D; Honda D; Melamed I; Savic S; Stobiecki M; Busse PJ; Dias de Castro E; Agmon-Levin N; Gower R; Kessel A; Kurowski M; Lleonart R; Grivcheva Panovska V; Wedner HJ; Audhya PK; Hao J; Iverson M; Smith MD; Yea CM; Lumry WR; Zanichelli A; Bernstein JA; Maurer M; Cohn DM;
N Engl J Med; 2024 May; ():. PubMed ID: 38819658
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Prophylactic Medications for the Treatment of Hereditary Angioedema Due to C1 Inhibitor Deficiency: A Real-World U.S. Perspective.
Zuraw BL
J Manag Care Spec Pharm; 2019 Feb; 25(2):148-151. PubMed ID: 30698094
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on acid attacks in the UK.
Shokrollahi K
Scars Burn Heal; 2017; 3():2059513117723769. PubMed ID: 29799561
[No Abstract] [Full Text] [Related]
8. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema.
Aberer W; Maurer M; Reshef A; Longhurst H; Kivity S; Bygum A; Caballero T; Bloom B; Nair N; Malbrán A
Allergy; 2014 Mar; 69(3):305-14. PubMed ID: 24438203
[TBL] [Abstract][Full Text] [Related]
9. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group.
Cicardi M; Aberer W; Banerji A; Bas M; Bernstein JA; Bork K; Caballero T; Farkas H; Grumach A; Kaplan AP; Riedl MA; Triggiani M; Zanichelli A; Zuraw B;
Allergy; 2014 May; 69(5):602-16. PubMed ID: 24673465
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting.
Maurer M; Longhurst HJ; Fabien V; Li HH; Lumry WR
Allergy Asthma Proc; 2014; 35(5):377-81. PubMed ID: 25198193
[TBL] [Abstract][Full Text] [Related]
11. Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals.
Hernández Fernandez de Rojas D; Ibañez E; Longhurst H; Maurer M; Fabien V; Aberer W; Bouillet L; Zanichelli A; Caballero T;
Int Arch Allergy Immunol; 2015; 167(1):21-8. PubMed ID: 26112099
[TBL] [Abstract][Full Text] [Related]
12. The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe.
Caballero T; Aygören-Pürsün E; Bygum A; Beusterien K; Hautamaki E; Sisic Z; Wait S; Boysen HB
Allergy Asthma Proc; 2014; 35(1):47-53. PubMed ID: 24268449
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey.
Aberer W; Maurer M; Bouillet L; Zanichelli A; Caballero T; Longhurst HJ; Perrin A; Andresen I;
Allergy Asthma Clin Immunol; 2017; 13():31. PubMed ID: 28690642
[TBL] [Abstract][Full Text] [Related]
14. Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe.
Zanichelli A; Magerl M; Longhurst H; Fabien V; Maurer M
Allergy Asthma Clin Immunol; 2013 Aug; 9(1):29. PubMed ID: 23937903
[TBL] [Abstract][Full Text] [Related]
15. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.
Baş M; Greve J; Hoffmann TK; Reshef A; Aberer W; Maurer M; Kivity S; Farkas H; Floccard B; Arcoleo F; Martin L; Sitkauskiene B; Bouillet L; Schmid-Grendelmeier P; Li H; Zanichelli A
Allergy; 2013 Nov; 68(11):1452-9. PubMed ID: 24111645
[TBL] [Abstract][Full Text] [Related]
16. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
17. Current state of hereditary angioedema management: a patient survey.
Banerji A; Busse P; Christiansen SC; Li H; Lumry W; Davis-Lorton M; Bernstein JA; Frank M; Castaldo A; Long JF; Zuraw BL; Riedl M
Allergy Asthma Proc; 2015; 36(3):213-7. PubMed ID: 25976438
[TBL] [Abstract][Full Text] [Related]
18. Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.
Malbrán A; Riedl M; Ritchie B; Smith WB; Yang W; Banerji A; Hébert J; Gleich GJ; Hurewitz D; Jacobson KW; Bernstein JA; Khan DA; Kirkpatrick CH; Resnick D; Li H; Fernández Romero DS; Lumry W
Clin Exp Immunol; 2014 Aug; 177(2):544-53. PubMed ID: 24749847
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin B2 receptor antagonist off label use in short-term prophylaxis in hereditary angioedema.
Angeletti C; Angeletti PM; Mastrobuono F; Pilotti L; Ciccozzi A; Guetti C
Int J Immunopathol Pharmacol; 2014; 27(4):653-9. PubMed ID: 25572747
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
